Home › Funds › Lynx1 Capital Management LP › KRRO

Lynx1 Capital Management LP position in KRRO

KORRO BIO INC · Health Care

Lynx1 Capital Management LP reported holding 1,538,296 shares of KRRO (KORRO BIO INC) in its Q2 2026 13F filing — a position valued at US$20.3M, representing 2.34% of its reported portfolio and ranking #6 among its reported holdings. Lynx1 Capital Management LP has disclosed KRRO holdings in 4 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)1.54M sh
Reported value held$20.27M
Portfolio Weight2.34%
First reportedQ2 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Lynx1 Capital Management LP's KRRO position evolved

Lynx1 Capital Management LP first disclosed a stake in KRRO in Q2 2024 at 3,800 shares (US$129K). The position peaked in Q2 2026 at 1,538,296 shares, worth US$20.3M. Across 4 filings, Lynx1 Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,538,296 shares valued at US$20.3M. Notable position changes include a 127% increase in Q1 2026 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 3.80K $128.71K New
Q4 2025 677.91K $5.43M New
Q1 2026 1.54M $17.41M Add
Q2 2026 1.54M $20.27M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KRRO and 13F data

KRRO (KORRO BIO INC) is a Health Care company. 37 other funds we track also report a position in KRRO — the largest reported positions include NEA Management Company, LLC (US$17.1M), Venrock Adviser, LLC (US$13.3M), Atlas Venture Life Science Advisors, LLC (US$12.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KRRO

All KRRO fund holders →

FAQ

How long has Lynx1 Capital Management LP held KRRO?

Lynx1 Capital Management LP has disclosed KRRO holdings in 4 of the last 9 reported quarters, going back to Q2 2024.

What is Lynx1 Capital Management LP's current position in KRRO?

As of Q2 2026, Lynx1 Capital Management LP holds 1.54M shares of KRRO (KORRO BIO INC), valued at $20.27M, representing 2.34% of its reported portfolio and ranking #6.

Has Lynx1 Capital Management LP been buying or selling KRRO?

In the latest 13F filing (Q2 2026), Lynx1 Capital Management LP held unchanged its position in KRRO. The position peaked in Q2 2026 at 1.54M shares.

Which other funds hold KRRO?

Other major institutional holders of KRRO include NEA Management Company, LLC, Venrock Adviser, LLC, Atlas Venture Life Science Advisors, LLC, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.